Makino, T., Otsuka, H., Hata, Y., Koezuka, S., Azuma, Y., Isobe, K., . . . Iyoda, A. (2018). Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery. Mol Clin Oncol.
Chicago Style CitationMakino, Takashi, et al. "Long-acting Muscarinic Antagonist and Long-acting β2-agonist Therapy to Optimize Chronic Obstructive Pulmonary Disease Prior to Lung Cancer Surgery." Mol Clin Oncol 2018.
MLA CitationMakino, Takashi, et al. "Long-acting Muscarinic Antagonist and Long-acting β2-agonist Therapy to Optimize Chronic Obstructive Pulmonary Disease Prior to Lung Cancer Surgery." Mol Clin Oncol 2018.
Warning: These citations may not always be 100% accurate.